Therapeutic Supply (Ibogaine/Neuroplastogens)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This subcontract under the Advanced Research Projects Agency for Health (ARPA-H) involves the manufacture and supply of clinical-grade active pharmaceutical ingredients or formulated drug products, specifically ibogaine or neuroplastogen-based therapeutics. The selected provider must support prime contractors on ASCENT-IBO projects by delivering pharmaceutical-grade compounds suitable for human trials. A critical requirement for this contract is the maintenance of Good Manufacturing Practice (GMP) certification to ensure all products meet strict clinical grade standards. The opportunity was posted on August 5, 2026, with a response deadline of October 15, 2026, falling under NAICS code 325412.
General Info
Agency
NAICS
Place of Performance
DC, USASet-Aside
Documents
This scope was carved out of ARPA-H-SN-26-158.
The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.
Area of Interest under PHO ISO: ASCENT-IBO
AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → Advanced Research Projects Agency For Health (arpa-H)
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
